TamEMLamRWLevittAJ. Treatment of seasonal affective disorder: A review. Can J Psychiatry1995;40:457–466.
2.
LamRWKripkeDFGillinJC. Phototherapy for depressive disorders: Areview. Can J Psychiatry1989;34:140–147.
3.
WehrTARosenthalNE. Seasonality and affective illness. Am J Psychiatry1989;146:829–839.
4.
BleharMCLewyAJ. Seasonal mood disorders: Consensus and controversy. Psychopharmacol Bull1990; 26:465–494.
5.
TermanMTermanJS, Quitkin FM, and others. Light therapy for seasonal affective disorder. A review of the efficacy. Neuropsychopharmacology1989;2:1–22.
6.
GrotaLJYerevanianBI, Gupta K, and others. Phototherapy for seasonal major depressive disorder: Effectiveness bright light of high or low intensity. Psychiatry Res1989;29:29–35.
7.
EastmanCILahmeyerHW, Watell LG, and others. A placebo-controlled trial of light treatment for winter depression. J Affect Disord1992; 26:211–221.
8.
TeicherMHGlodCA, Oren DA, and others. The phototherapy visor: There is more to it than meets the eye. Am J Psychiatry1995; 152:1197–1202.
9.
LeeTMC. Phototherapy for SAD: A meta-analytic review. A thesis submitted to the faculty of graduate studies in partial fulfillment of the requirements for the degree of doctor in philosophy in school psychology. Department of Educational Psychology, University of Alberta, Edmonton, Alberta. Fall, 1995.
10.
KramlingerKGPetersonGCWatsonPKLeonardLL. Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics1981;26:67–71.
11.
RavarisCLMichaelSJBerozaKWNoordsyDLBrinck-JohnsenT. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman. Arch Gen Psychiatry1988;45:966–967.
12.
BealeMDAranaGW. Dexamethasone for treatment of major depression in patients with bipolar disorder. Am J Psychiatry1995;152:959–960.
13.
JeffcoateWJSilverstoneJTEdwardsCRWBesserGM. Psychiatric manifestations of Cushing's syndrome: Response to lowering plasma Cortisol. QJM1979;48:465–472.
14.
DubrovskyBFilipiniDLGijsbersKBirminghamMK. Early and late effects of steroid hormones on the nervous system. In: SimmondsMA, editor. Ciba Symposium 153: Steroids and Neural Activity. Chichester (UK): Wiley. 1990. p 240–260.
15.
DubrovskyB. Effects of adrenal cortex hormones on limbic structures: Some experimental and clinical correlations related to depression. J Psychiatry Neurosci1993;18:4–16.
16.
PychaCGulledgeADHutzlerJKadriNMaloneyJ. Psychological responses to the implantable defribillatior: Preliminary observations. Psychosomatics1986;27:841–845.
17.
KerenRAaronsDVeltriE. Anxiety and depression in patients with life-threatening ventricular arrhythmias: Impact of the implantable cardioverter-defibrillator. Pacing Clin Electrophysiol1991;14:181–187.
18.
RoyALinnoilaM. Alcoholism and suicide. Suicide Life Threat Behav1986;16:244–273.
19.
LoosenPDewBPrangeA. Long-term predicators of outcome in abstinent alcoholic men. Am J Psychiatry1990;147:1662–1666.
20.
FreudS. On the general effects of cocaine (1885). Drug Dependence1970;5:15–17.
21.
SalzamC. Listening to Prozac: a psychiatrist explores antidepressant drugs and the remaking of self [book review]. Am J Psychiatry1994;151:610–611.
22.
KramerPD. The music of what happens. Psychiatric Times1993 Oct;9(10):4.
23.
KramerPP. Upon mature consideration. Psychiatric Times1991 Feb;7(2):4.
24.
TurnerJADeyoRALoeserJDVonkorfMFordyceWE. The importance of placebo effects in pain treatment and research. JAMA1994;271:1609–1614.
25.
GrayP. The assault on Freud. Time1993 Nov 29:47–51.
26.
The Bible. Ecclesiastes3:1–8.
27.
JacksonSW. The listening healer in the history of psychological healing. Am J Psychiatry1992;149:1623–1632.
28.
KhouzamHR. Getting psychiatry back on track. Clinical Psychiatry News1991 Aug;19(8):7.
29.
BemJLKerrLStüchlerD. Mefloquine prophylaxis: An overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg1992;95:167–179.
30.
World Health Organization. Review of central nervous system adverse events related to anti-malarial drug mefloquine (1985–1990). Geneva: World Health Organization; 1991.
CaillonESchmittLMoronP. Acute depressive symptoms after mefloquine treatment. Am J Psychiatry1992;149:712.
33.
ZubinJSpringB. Vulnerability—a new view of schizophrenia. J Abnorm Psychol1977;86:103–126.
34.
MarderSRMeibachRC. Risperidone in the treatment of schizophrenia. Am J Psychiatry1994;151:825–835.
35.
KeckPEWilsonDR, Strakowski SM, and others. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Proceedings of the Annual Meeting of the American Psychiatric Association; 1995 May; Miami (FL).
36.
Van PuttenTMayPRA. “Akinetic depression” in schizophrenia. Arch Gen Psychiatry1978;35:1101–1107.